Healthcare
Straumann Holding AG(SAUHY)
Live Price
Offline$13.14
+3.02% today
1Y Change
-7.40%
Window
Jun 23, 2025 โ Jun 12, 2026
- Market Cap
- $13.47B
- Revenue Growth
- -0.6%
- EPS Growth
- -10.8%
- Dividend Yield
- 1.2%
Coverage: 245 bars ยท Jun 23, 2025 โ Jun 12, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Straumann Holding AG (SAUHY) is a Healthcare stock with a market cap of $13.47B and listed on OTC. The stock last traded around $13.13 and down 7.4% across the available one-year price window (Jun 23, 2025 โ Jun 12, 2026). Baseline metrics include revenue growth of -0.6%, EPS growth of -10.8%, a dividend yield of 1.2%. What stands out right now is revenue -0.6%, EPS -10.8%, free cash flow -0.2% with operating margin 44.1% and ROIC 30.1%. The dividend is present but secondary, with a yield around 1.2%. Valuation already assumes a fairly strong business story at P/E 37.6 and price/sales 5.2. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines SAUHY price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Below sector median
-0.6% vs +7.6% peer median
Operating Margin
Above sector median
+44.1% vs +19.4% peer median
P/E
Near sector median
37.6 vs 36.3 peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report came in below the EPS bar
2026 was reported on Feb 18, 2026 with an EPS surprise of -2.8% and a revenue surprise of +4.2%.
The operating picture looks softer than before
Revenue is at -0.6% and EPS is at -10.8%, with operating margin around 44.1%.
The next real check-in already has a date
The next earnings event is scheduled for Aug 19, 2026, which is the clearest near-term catalyst for confirming whether the current trend is holding up.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged -0.1% over the next 5 trading days and finished higher after 2 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 Feb 18, 2026 | -2.8% | -2.6% | -4.5% | -20.3% |
2025 Jun 30, 2025 | -16.5% | +1.9% | +1.7% | +3.2% |
2024 Dec 31, 2024 | -28.6% | +2.5% | +2.7% | +4.1% |
Benchmark Comparison
Normalized Performance vs SPY
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
SAUHY
โ
Normalized return
SPY
โ
S&P 500
Excess Return
โ
Relative to SPY
SAUHY Max Drawdown
-31.50%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for SAUHY and SPY.
Company Overview
Straumann Holding AG
Other OTC
Straumann Holding AG provides tooth replacement and orthodontic solutions worldwide. It researches, develops, manufactures, and supplies dental implants, instruments, CADCAM prosthetics, orthodontic aligners, biomaterials, and digital solutions for use in tooth correction, replacement, and restoration, as well as to prevent tooth loss. The company offers dental implant systems for tissue and bone level; titanium, titanium alloy, ceramic, and mini dental implant systems; and guided and non-guided surgical instruments, as well as implant-borne prosthetics. It provides ceramic healing and screw retained abutments; intraoral scanning solutions; 3D printers; milling machines; and prevention products. In addition, it offers biomaterials, bone substitutes, membranes, biologics, and soft tissue management and oral healing products; digital solutions for dental labs, dentists, and centralized milling centers, as well as materials, third party systems, and guided surgery; surgical instruments comprising surgical and modular cassettes, guided instruments, implant maintenance products, bone block fixation sets, bonerings, titanium pin sets, and other cassettes; and edentulous, pro arch fixed, prosthetic, and mini implant solutions for edentulous patients. Further, it provides esthetic restorations that include ceramic implant monotypes, ceramic implants, abutments, biologics, and other solutions; and Emdogain for wound healing. Further, it offers systems Clear Correct aligners; and training and education services to its customers. The company provides its products to general dentists, specialists, and dental technicians and laboratories, as well as corporate customers, such as distributors, hospitals, universities, and dental service organizations in approximately 100 countries through a network of distribution subsidiaries and partners. Straumann Holding AG was founded in 1954 and is headquartered in Basel, Switzerland.
- Leadership
- Guillaume Daniellot
- IPO Date
- Dec 19, 2014
- Employees
- 11.3k
- Street Address
- Peter Merian-Weg 12
- Mailing
- Basel, 4002
- Region
- Basel, CH
- Reporting Currency
- USD
- Investor Line
- 41 61 965 11 11
- Last Updated
- May 4, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- 37.6
- EV/EBITDA
- 10.9
- Price/Sales
- 5.2
- Price/Book
- 6.2
Growth
- Revenue
- -0.6%
- EPS
- -10.8%
- Free Cash Flow
- -0.2%
Profitability
- Gross Margin
- 68.7%
- Operating Margin
- 44.1%
- Net Margin
- 13.7%
- ROE
- 16.9%
- ROIC
- 30.1%
Balance Sheet
- Debt/Equity
- 0.30
- Current Ratio
- 2.21
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.